A new study suggests that people with Alzheimer’s on the drug risperidone, an antipsychotic drug often prescribed as the brand name Risperdal, may be better off continuing to take the drug if they have not experienced negative side effects.
Because of the potential side effects, risperidone is only recommended to be prescribed for three to six months. After that point, a written explanation is required to continue the drug. A study, published in the New England Journal of Medicine and funded by the National Institutes of Health, investigated the effects of discontinuing the medication among individuals who had seen improvements as a result of the drug. Researchers prescribed risperidone to individuals with Alzheimer’s disease who showed signs of agitation and aggression. After 16 weeks, researchers put half of the individuals who did well on the drug on a placebo. The other half continued the treatment. The study found that those on the placebo were twice as likely to have their symptoms return. The rate of side effects and death were equal among the two groups.
Researchers warned that antipsychotics can carry the risk of serious side effects and should not be used on all individuals with Alzheimer’s disease, but discontinuing medication that has achieved benefits is not always the right choice. "One must be cautious about discontinuing the medication,” said study author Dr. D.P. Devanand, director of the division of geriatric psychiatry at Columbia Psychiatry and the New York State Psychiatric Institute in New York City. “If a person does well on it and there are not too many side effects, maybe they should stay on it for a while and be monitored closely."
For more information, read the article: Some With Alzheimer's Better Off Staying on Antipsychotics: Study Or, read the full study: Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease.
End of Life, Falls Prevention, Health and Wellness, Managed Risk
Researchers analyzed data among individuals age 65 and over and found an 8 percent increase in falls, or about a 30 percent rise in falls, from 1998-2...
End of Life, Facts and Figures, Hospice, Medicare, Partnerships, Reports
Medicare payments for hospice care in assisted living communities has more than doubled in five years, totaling $2.1 billion in 2012, according to a n...
Congress recently signed a funding bill including the Alzheimer’s Accountability Act, enabling scientists at the National Institutes of Health to tell...
cheatsheet, Clinical Quality and Quality Care Delivery, Facts and Figures, Health and Wellness, Managed Risk
The Centers for Disease Control and Prevention released data last month showing that the flu is now widespread across the United States, although it’s...
Health and Wellness, Health Care, Hearings, Medication Management
The Senate Special Committee on Aging released a report focusing on ways to increase the use of generic drugs within the Medicare Part D program, and ...
Business, CEO, cheatsheet, Clinical Quality and Quality Care Delivery, Community Awareness and Education, Human Resources and Organizational Development, Public Policy, Research, Resident and Family Services, Science and Technology
As you begin the new year, make sure you don’t miss the biggest senior living stories of 2014. Last year’s most widely read topics include innovative ...
cheatsheet, Consumer Intelligence, Disabilities, End of Life, Facts and Figures, Health and Wellness, Managed Risk, Reports
The future of disability among older American adults will be affected by how the United States prepares for and manages a complex array of fiscal, med...
Allied Member, Best of the Best Awards, Business, CEO, cheatsheet, Clinical Quality and Quality Care Delivery, Community Awareness and Education, Community Leadership, Engage, Hero Awards, Human Resources, Marketing Strategy, Membership, Provider Member
ALFA’s annual awards program is now open for nominations, but the window is closing fast. Please consider nominating your most innovative people, proc...
Accessiblity Issues, Disabilities, Falls Prevention, Science and Technology
A new robot research project hopes to provide a solution for people who have limited hand functionality and who rely on wheelchairs for mobility. Rese...
cheatsheet, Health and Wellness, Managed Risk
The Centers for Disease Control and Prevention has released a long-term care toolkit with resources for senior living communities to provide access to...